Digital Art Activity for Cancer Patients

This study is exploring whether a digital art activity can help adult cancer patients better express their symptoms and feelings of distress. Participants will complete symptom questionnaires and engage in either a digital art activity or listen to meditative music. Researchers will then see if the digital art activity changes how patients report their symptoms, using a tool called the Edmonton Symptom Assessment System (ESAS). You may be able to join if you are an adult (18 or older) admitted to the hospital with a cancer diagnosis (solid or blood cancer) and are receiving active treatment. You also need to be able to use a digital tablet and speak English or Spanish. The study aims to enroll 60 participants. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will observe participants without assigning specific treatments. It plans to enroll 60 adult cancer patients.
What's involved
You will complete symptom questionnaires and engage in either a digital art activity or listen to meditative music. This will occur over an average of one year.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed through study completion, which is an average of one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06127121

A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

Active, Not Recruiting
Not specifiedAges 18+Observational
M.D. Anderson Cancer Center
~74 participants
Updated 2026-08-20 on ClinicalTrials.gov
What's tested:Digital Art Activity

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The Edmonton Symptom Assessment System, (ESAS) questionnaires
Measured over through study completion; an average 1 year.
Cancer
1 sites across 1 states
Texas1
  • Carlos Roldan, MD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • The Edmonton Symptom Assessment System, (ESAS) questionnairesthrough study completion; an average 1 year.

    Score Scale (0-10) 0 No symptom-10 Worst possible